elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35050195-DE64894B-DC9C-4222-B079-EBBD6D3D142A
Q35050195-DE64894B-DC9C-4222-B079-EBBD6D3D142A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35050195-DE64894B-DC9C-4222-B079-EBBD6D3D142A
Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.
P921
Q35050195-DE64894B-DC9C-4222-B079-EBBD6D3D142A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35050195-DE64894B-DC9C-4222-B079-EBBD6D3D142A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
82630af7e1151e88e8ae34ab9d05aea66cb2f3b3
P921
Insulin